Yuanyuan Wu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Spatial multi-omics analysis of tumor-stroma boundary cell features for predicting breast cancer progression and therapy response.
Journal: Frontiers in cell and developmental biology
Published: February 04, 2025
Integrated network pharmacology and experimental verification to explore the potential mechanism of San Ying decoction for treating triple-negative breast cancer.
Journal: Acta biochimica et biophysica Sinica
Published: March 22, 2024
Xianling Lianxia formula enhances the inhibitory effects of trastuzumab on HER2-positive breast cancer.
Journal: Acta biochimica et biophysica Sinica
Published: February 21, 2024
Identifying a locus in super-enhancer and its resident NFE2L1/MAFG as transcriptional factors that drive PD-L1 expression and immune evasion.
Journal: Oncogenesis
Published: May 13, 2023
Investigating the Immunogenic Cell Death-Dependent Subtypes and Prognostic Signature of Triple-Negative Breast Cancer.
Journal: Phenomics (Cham, Switzerland)
Published: May 06, 2023
Extract of Platycodon grandiflorum Prevents Doxorubicin-induced Cardiotoxicity in Breast Cancer.
Journal: Integrative cancer therapies
Published: April 08, 2023
Identifying the anti-metastasis effect of Anhydroicaritin on breast cancer: Coupling network pharmacology with experimental validation.
Journal: Journal of ethnopharmacology
Published: February 17, 2022
Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma.
Journal: Frontiers in cell and developmental biology
Published: September 08, 2021
Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis.
Journal: Frontiers in cell and developmental biology
Published: August 25, 2021
Malignant Tumor Purity Reveals the Driven and Prognostic Role of CD3E in Low-Grade Glioma Microenvironment.
Journal: Frontiers in oncology
Published: March 04, 2021
Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell.
Journal: Experimental and molecular pathology
Published: July 20, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026